{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T06:55:06Z","timestamp":1768200906569,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jdcjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jdiacomp.2016.11.012","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T15:02:16Z","timestamp":1479394936000},"page":"583-588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Associations between FGF21, osteonectin and bone turnover markers in type 2 diabetic patients with albuminuria"],"prefix":"10.1016","volume":"31","author":[{"given":"Lingling","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weibo","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengying","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0005","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.bone.2005.11.017","article-title":"Matricellular proteins: Extracellular modulators of bone development, remodeling, and regeneration","volume":"38","author":"Alford","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0010","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1210\/en.2014-1083","article-title":"FGF21 and skeletal remodeling during and after lactation in C57BL\/6J mice","volume":"155","author":"Bornstein","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0015","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1359\/jbmr.2003.18.6.1005","article-title":"Infrared analysis of the mineral and matrix in bones of steonectin- null mice and their wildtype controls","volume":"18","author":"Boskey","year":"2003","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0020","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1172\/JCI12939","article-title":"SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury","volume":"107","author":"Bradshaw","year":"2001","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0025","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.2337\/dc09-0684","article-title":"Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance","volume":"32","author":"Chavez","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0030","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.2337\/dc11-0294","article-title":"High plasma level of fibroblast growth factor 21 is an independent predictor of type 2 diabetes: A 5.4-year population-based prospective study in Chinese subjects","volume":"34","author":"Chen","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0035","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/ATVBAHA.113.301599","article-title":"Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors","volume":"33","author":"Chow","year":"2013","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ndt\/gfs290","article-title":"Role of insulin resistance in kidney dysfunction: insights into the mechanism and epidemiological evidence","volume":"28","author":"De Cosmo","year":"2013","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0045","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1172\/JCI7039C1","article-title":"Osteopenia and decreased bone formation in osteonectin- deficient mice","volume":"105","author":"Delany","year":"2000","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0050","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1210\/en.2002-221044","article-title":"The osteonectin-null mutation compromises osteoblast formation, maturation, and survival","volume":"144","author":"Delany","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0055","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/jbmr.2378","article-title":"A single nucleotide polymorphism in osteonectin 3' untranslated region regulates bone volume and is targeted by miR-433","volume":"30","author":"Dole","year":"2015","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0060","doi-asserted-by":"crossref","first-page":"F577","DOI":"10.1152\/ajprenal.00393.2004","article-title":"Mechanical strain increases SPARC levels in podocytes: Implications for glomerulosclerosis","volume":"289","author":"Durvasula","year":"2005","journal-title":"American Journal of Physiology - Renal Physiology"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0065","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.2337\/db10-0193","article-title":"Obesity is a fibroblast growth factor 21 (FGF21)-resistant state","volume":"59","author":"Fisher","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0070","doi-asserted-by":"crossref","first-page":"758","DOI":"10.4158\/EP12141.RA","article-title":"Bone as an endocrine organ","volume":"18","author":"Guntur","year":"2012","journal-title":"Endocrine Practice"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0075","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/aje\/kwm106","article-title":"Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture","volume":"166","author":"Janghorbani","year":"2007","journal-title":"American Journal of Epidemiology"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0080","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1007\/s00198-014-2714-5","article-title":"Suppressed bone turnover was associated with increased osteoporotic fracture risks in non-obese postmenopausal Chinese women with type 2 diabetes mellitus","volume":"25","author":"Jiajue","year":"2014","journal-title":"Osteoporosis International"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0085","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.metabol.2011.10.012","article-title":"Association between serum fibroblast growth factor 21 and diabetic nephropathy","volume":"61","author":"Jian","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0090","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1007\/s001250051493","article-title":"Secreted protein acidic and rich in cysteine (SPARC) in patients with diabetic nephropathy and tubulointerstitial injury","volume":"43","author":"Kanauchi","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0095","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1146\/annurev.cellbio.042308.113308","article-title":"Genetic control of bone formation","volume":"25","author":"Karsenty","year":"2009","journal-title":"Annual Review of Cell and Developmental Biology"},{"issue":"Suppl. 2","key":"10.1016\/j.jdiacomp.2016.11.012_bb0100","first-page":"S12","article-title":"KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease","volume":"49","author":"KDOQI","year":"2007","journal-title":"American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0105","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1210\/jc.2014-3465","article-title":"Circulating fibroblast growth factor 21 levels predict progressive kidney disease in subjects with type 2 diabetes and normoalbuminuria","volume":"100","author":"Lee","year":"2015","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0110","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1007\/s00198-013-2464-9","article-title":"Fibroblast growth factor 21 (FGF21) and bone: Is there a relationship in humans?","volume":"24","author":"Lee","year":"2013","journal-title":"Osteoporosis International"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0115","doi-asserted-by":"crossref","first-page":"e15534","DOI":"10.1371\/journal.pone.0015534","article-title":"Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile","volume":"5","author":"Lin","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0120","doi-asserted-by":"crossref","first-page":"e18398","DOI":"10.1371\/journal.pone.0018398","article-title":"Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese","volume":"6","author":"Lin","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0125","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1359\/jbmr.2000.15.4.613","article-title":"Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib","volume":"15","author":"Mashiba","year":"2000","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.genm.2012.03.004","article-title":"Diabetic polyneuropathy relates to bone metabolism and markers of bone turnover in elderly patients with type 2 diabetes: Greater effects in male patients","volume":"9","author":"Rasul","year":"2012","journal-title":"Gender Medicine"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0135","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1210\/jcem.86.1.7139","article-title":"Older women with diabetes have an increased risk of fracture: A prospective study","volume":"86","author":"Schwartz","year":"2001","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0140","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00198-011-1595-0","article-title":"Bone structure and turnover in type 2 diabetes mellitus","volume":"23","author":"Shu","year":"2012","journal-title":"Osteoporosis International"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0150","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1359\/JBMR.040311","article-title":"Diabetes is associated independently of body composition with BMD and bone volume in older white and black men and women: The health, aging, and body composition study","volume":"19","author":"Strotmeyer","year":"2004","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0155","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cmet.2015.12.008","article-title":"FGF21 regulates sweet and alcohol preference","volume":"23","author":"Talukdar","year":"2016","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0160","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/01.ASN.0000054498.83125.90","article-title":"Amelioration of diabetic nephropathy in SPARC-null mice","volume":"14","author":"Taneda","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0165","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.2337\/diacare.22.7.1196","article-title":"Bone mineral density in patients with type 1 and type 2 diabetes","volume":"22","author":"Tuominen","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0170","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s00125-005-1786-3","article-title":"Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk","volume":"48","author":"Vestergaard","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0175","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/8756-3282(93)90252-6","article-title":"Bone mineral density measured by dual energy X-ray absorptiometry in patients with non-insulin-dependent diabetes mellitus","volume":"14","author":"Wakasugi","year":"1993","journal-title":"Bone"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0180","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1073\/pnas.1200797109","article-title":"Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor gamma","volume":"109","author":"Wei","year":"2012","journal-title":"Proceedings of the National Academy Sciences of the United States of America"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0185","doi-asserted-by":"crossref","first-page":"26060","DOI":"10.1074\/jbc.M112.343707","article-title":"Fibroblast growth factor 21(FGF21) inhibits chondrocyte function and growth hormone action directly at the growth plate","volume":"287","author":"Wu","year":"2012","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0190","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1210\/jc.2011-2537","article-title":"Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes","volume":"97","author":"Yamamoto","year":"2012","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0195","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1359\/jbmr.081207","article-title":"Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications","volume":"24","author":"Yamamoto","year":"2009","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.jdiacomp.2016.11.012_bb0200","doi-asserted-by":"crossref","first-page":"e82275","DOI":"10.1371\/journal.pone.0082275","article-title":"Attenuation of hyperlipidemia- and diabetes-induced early-stage apoptosis and late-stage renal dysfunction via administration of fibroblast growth factor-21 is associated with suppression of renal inflammation","volume":"8","author":"Zhang","year":"2013","journal-title":"PloS One"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105687271630856X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105687271630856X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T12:23:23Z","timestamp":1536236603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105687271630856X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S105687271630856X"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2016.11.012","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations between FGF21, osteonectin and bone turnover markers in type 2 diabetic patients with albuminuria","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2016.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}